Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing Pumitamig plus chemotherapy to Bevacizumab plus chemotherapy in previously untreated, unresectable, or metastatic colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Pumitamig

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Untreated, Unresectable, or Metastatic Colorectal Cancer | Phase 2, Phase 3 | Status: RECRUITING